ONWARD Announces Results of Annual General Meeting of Shareholders
08 Maio 2023 - 10:57AM
ONWARD Announces Results of Annual General Meeting of
Shareholders
ONWARD Medical N.V. (Euronext: ONWD), the medical technology
company creating innovative therapies for people with spinal cord
injury, today announces all proposed resolutions at its Annual
General Meeting of Shareholders (AGM) were duly passed. The meeting
was held this afternoon in Amsterdam, the Netherlands at
2.00 p.m. CET. Full details of the resolutions approved during
the AGM can be found on IR.ONWD.com.
To learn more about ONWARD ARC Therapy™ and the
Company’s vision to restore movement, function, and independence in
people with spinal cord injury, please visit ONWD.com.
About ONWARD®
Medical
ONWARD is a medical technology company creating
innovative therapies to restore movement, function, and
independence in people with spinal cord injuries. The Company’s
work builds on more than a decade of basic science and preclinical
research conducted at the world’s leading neuroscience
laboratories. ONWARD ARC Therapy™, which can be delivered by
implantable (ARC-IM™) or external (ARC-EX™) systems*, is designed
to deliver targeted, programmed spinal cord stimulation to restore
movement and other functions in people with spinal cord injury,
ultimately improving their quality of life.
ONWARD has received eight Breakthrough Device
Designations from the US FDA. ARC-EX is an external, non-invasive
platform consisting of a stimulator and wireless programmer.
Positive top-line data were reported in 2022 from the Company’s
first pivotal study, called Up-LIFT, evaluating the ability of
transcutaneous ARC Therapy to improve upper extremity strength and
function. The Company is now preparing marketing approval
submissions for the US and Europe. ARC-IM consists of an
implantable pulse generator and lead placed near the spinal cord.
The Company completed the first-in-human use of the ARC-IM
neurostimulator and reported positive interim clinical outcomes for
ARC-IM Therapy for improved blood pressure regulation following SCI
in 2022.
ONWARD is headquartered in Eindhoven, the
Netherlands. It maintains a Science and Engineering Center in
Lausanne, Switzerland, and has a growing US presence in Boston,
Massachusetts. The Company has an academic partnership with
.NeuroRestore, a collaboration between EPFL, the Swiss Federal
Institute of Technology in Lausanne, and Lausanne University
Hospital (CHUV). For additional information about the Company,
please visit ONWD.com. To access our 2023 Financial Calendar,
please visit IR.ONWD.com.
*Devices are for investigational use only
For Company Enquiries:info@onwd.com
For Media Enquiries: Aditi Roy, VP
Communicationsmedia@onwd.com
For Investor Enquiries:Lara Smith Weber, CFO
investors@onwd.com
Disclaimer
Certain statements, beliefs, and opinions in
this press release are forward-looking, which reflect the Company’s
or, as appropriate, the Company directors’ current expectations and
projections about future events. By their nature, forward-looking
statements involve several risks, uncertainties, and assumptions
that could cause actual results or events to differ materially from
those expressed or implied by the forward-looking statements. These
risks, uncertainties, and assumptions could adversely affect the
outcome and financial effects of the plans and events described
herein. A multitude of factors including, but not limited to,
changes in demand, competition, and technology, can cause actual
events, performance, or results to differ significantly from any
anticipated development. Forward-looking statements contained in
this press release regarding past trends or activities should not
be taken as a representation that such trends or activities will
continue in the future. As a result, the Company expressly
disclaims any obligation or undertaking to release any update or
revisions to any forward-looking statements in this press release
as a result of any change in expectations or any change in events,
conditions, assumptions, or circumstances on which these
forward-looking statements are based. Neither the Company nor its
advisers or representatives nor any of its subsidiary undertakings
or any such person’s officers or employees guarantees that the
assumptions underlying such forward-looking statements are free
from errors nor does either accept any responsibility for the
future accuracy of the forward-looking statements contained in this
press release or the actual occurrence of the forecasted
developments. You should not place undue reliance on
forward-looking statements, which speak only as of the date of this
press release.
Onward Medical NV (EU:ONWD)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Onward Medical NV (EU:ONWD)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024